(Reuters) - The U.S. subsidiary of global pharmaceutical company Daiichi Sankyo Co Ltd has agreed to pay $39 million to the U.S. government and state Medicaid programs to settle claims it paid doctors kickbacks to prescribe its drugs, the Department...
Company: DAIICHI SANKYO INC; DAIICHI SANKYO CO LTD
News Subject: (Legal (1LE33); Government Litigation (1GO18))
Industry: (Pharmaceuticals Cost-Benefits (1PH30); Pharmaceuticals & Biotechnology (1PH13); Pharmaceuticals (1PH33); Generic Drugs (1GE93))
Other Indexing: (Kathy Fragoules; Mark Blinch; Ken Keller)
Keywords: health; antitrust (MCC:OEC); (N2:US); (N2:AMERS); (N2:USA); (MCCL:OVR)